About 11,310 people died in what was the largest outbreak of the virus ever recorded.
Two new clinical treatments for the infamous Ebola virus may result in it becoming a "preventable and treatable" disease, the BBC reported on Tuesday, with a study of four drugs finding that two treatments called REGN-EB3 and mAb114 were effective in limiting mortality from the disease.
When caught, the Ebola virus causes fever, intense weakness, muscle pain and a sore throat.
The survival rate of patients with low levels of the virus in their blood was as high as 94% when they were given REGN-EB3, as well as 89% when on mAb114.
Regeneron's (REGN.O) REGN-EB3 and mAb114 (a monoclonal antibody) have both proven extremely effective, with more than 85 percent of people prescribed the drugs surviving if diagnosed early on in the disease's development.
Patients who were receiving two other drugs that are being discontinued, Zmapp and remdesivir, will now have the option at the discretion of their treating physician to receive the treatments that have been shown to work. Going forward, mAb114 and REGN-EB3 will be the only Ebola drugs used in future trials. Hence, early detection of the disease is better than cure, learn to listen to others for better health.
"The trial will have saved lives". This, because two drugs being tested in an ongoing major outbreak in the Democratic Republic of the Congo (DRC) were found to have significantly reduced the disease's death rate.
More than 90% of infected people can survive if treated early with the most effective drugs, the research showed. "This trial is a remarkable advance in the decades-long struggle to respond to Ebola and we appreciate the tremendous efforts of the many governmental and non-governmental organizations who made it possible".
Prof Jean-Jacques Muyembe, Director-General of the Institut National de Recherche Biomédicale in DRC, said, "From now on, we will no longer say that Ebola is incurable".
"Getting people into care more quickly is absolutely vital", Ryan said.
Scientists say the results are very good news for the fight against Ebola as the news marks a first for people who already have been infected.
The trial, which started in November previous year, is being carried out by an worldwide research group coordinated by the WHO.
The recent outbreak, however, is highly complex.
Democractic Republic of the Congo in Africa. Now, there are 2,671 cases of EVD, with 1,790 deaths.
World Bank-backed insurance schemes to help poor countries tackle pandemics quickly have not paid out despite more than 1,800 people dying of Ebola in Democratic Republic of Congo over the previous year, the second-worst outbreak on record, according to Reuters.